Germany’s Stada Arzneimittel has struck a deal with United Arab Emirates' Adcan Pharma to expand its consumer healthcare presence across the Middle East and Africa (MENA) regions.
The first stage of the strategic partnership between the two companies will see Stada exclusively market and commercialize in the UAE a portfolio of 15
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?